Popular on Rezul
- Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
- Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
- Tatanka Run Announces Phase-2 Development Following Completion of Phase-1 Spec Home
- Data Over Drama: Market Trends 2026 to discuss what's next for Florida's real estate market
- UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
- Laurie McLennan and The McLennan Team Announces Strong Finish to 2025 With Notable Luxury Sales in La Quinta and Palm Desert
- T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
- From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
- Beucher Insurance Agency Responds to Historic Rain Event in North Lake County Florida
- Zacuto Group Brokers Sale of 1936 Mateo Street in Downtown Los Angeles
Similar on Rezul
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- Women's Everyday Safety Is Changing - The Blue Luna Shows How
- AI-Driven Cybersecurity Leader Gains Industry Recognition, Secures $6M Institutional Investment, Builds Momentum Toward $16M Annual Run-Rate Revenue
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- New Angles US Group Founder Alexander Harrington Receives Top U.S. Corporate Training Honor and Leads Asia-Pacific Engagements in Taiwan
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor
- EnergyStrat Launches Global LNG Risk Outlook 2025–2030
- Strong Revenue Gains, Accelerating Growth, Strategic Hospital Expansion & Uplisting Advancements: Cardiff Lexington Corporation (Stock Symbol: CDIX)
Lab Tests Reveal Majority of Products Contain Less CBD than Advertised
Rezul News/10443739
RALEIGH, N.C., Dec. 3, 2019 /PRNewswire/ -- Remedy Review, the venture capital-backed independent observer for natural health, recently conducted lab tests of CBD products. The results reinforce the need for independent monitoring and testing.
Tested products included some sent to the company for review and others purchased from prominent e-commerce platforms. Each of the products was tested for cannabinoid content, terpenes, heavy metals, pesticides, and residual solvents. Cannabinoid tests were used to measure label accuracy.
"Demand for CBD has outpaced quality control standards," said Marc Lewis, Executive Editor of Remedy Review. "Brands that bring poor quality products to market put consumers at risk, waste people's money, and erode trust in a promising new product category."
Lab tests were conducted at Avazyme, Inc., a contract research and testing laboratory based in Durham, North Carolina.
"We at Avazyme, support the entire hemp value chain from Farm to Farmacy, with our accurate and reliable testing solutions and openness in knowledge sharing," said Volker Bornemann, Ph.D., CEO of Avayzme, Inc. "Our goal is to ensure that our customers meet the highest standards of product safety and product quality, thereby fostering trust with their clients and their end-consumers."
More on Rezul News
As an independent observer, Remedy Review hopes its Seal of Approval will aid consumers in a confusing space by adding an additional layer of scrutiny to a growing online marketplace.
A summary of test results can be found at https://www.remedyreview.com/industry/lab-test-results.
About Remedy Review
Remedy Review is dedicated to advancing the wellness of people. Since its launch in October of 2018, the site has published articles on the medical, economic, and lifestyle potential of hemp. For people buying CBD online, Remedy Review is the only product review site that uses 3rd-party testing to protect consumers and hold brands accountable.
For more information, please visit: https://www.remedyreview.com
About Avazyme, Inc.
Avazyme, Inc. offers custom-tailored testing solutions for agriculture, pesticide and biopesticide, biotechnology and pharmaceutical industries and the entire food value chain, performed under the highest quality standards, including GLPs. The founder, President and CEO of Avazyme, Volker Bornemann, Ph.D., is also an adjunct professor at NCSU and on the AgTech Scientific Advisory Board of the North Carolina Biotechnology Center. Avazyme has acquired the state and federal permits to legally handle any controlled substances (DEA Schedule 1 through 5), including Cannabis and products derived thereof, at its laboratory facility.
For more information, please visit: https://www.avazyme.com
More on Rezul News
CONTACT:
Marc Lewis
Executive Editor
marc@remedyreview.com
LEGAL:
Remedy Review does NOT provide any medical advice, diagnosis, or treatment. If you need medical advice, diagnosis, or treatment, please see a physician and do NOT use Remedy Review for that purpose. Further, Remedy Review does not and cannot recommend treatment or offer medical advice on personal health matters. The contents contained herein and on remedyreview.com, including but not limited to all product information, are for informational purposes only and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. The contents on remedyreview.com shall not be used as a substitute for professional diagnosis or treatment. Your access to or use of the remedyreview.com does not create in any way a physician-patient relationship, any sort of confidential relationship, or any other relationship that would give rise to any duties on the part of Remedy Review, its agents, or employees. Always seek the advice of a qualified healthcare professional with any questions you may have regarding any medical condition. Never disregard medical advice or delay in seeking medical advice because of something you have read on remedyreview.com. In case of an emergency, call 911 for immediate assistance. Remedy Review makes best efforts to present accurate information in its testing and works with highly credentialed ISO-certified laboratories to produce test results. Neither Remedy Review nor any party involved in creating, producing or delivering remedyreview.com shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user's access, use, or inability to use remedyreview.com, or any errors or omissions in the content of remedyreview.com.
SOURCE Remedy Review
Related Links
https://www.remedyreview.com
- 8 of 15 products were mislabeled—containing at least 20% less CBD than advertised
- All gummies tested were mislabeled—one contained zero CBD
- 60% of vape liquids contained flammable, toxic solvents or pesticides
Tested products included some sent to the company for review and others purchased from prominent e-commerce platforms. Each of the products was tested for cannabinoid content, terpenes, heavy metals, pesticides, and residual solvents. Cannabinoid tests were used to measure label accuracy.
"Demand for CBD has outpaced quality control standards," said Marc Lewis, Executive Editor of Remedy Review. "Brands that bring poor quality products to market put consumers at risk, waste people's money, and erode trust in a promising new product category."
Lab tests were conducted at Avazyme, Inc., a contract research and testing laboratory based in Durham, North Carolina.
"We at Avazyme, support the entire hemp value chain from Farm to Farmacy, with our accurate and reliable testing solutions and openness in knowledge sharing," said Volker Bornemann, Ph.D., CEO of Avayzme, Inc. "Our goal is to ensure that our customers meet the highest standards of product safety and product quality, thereby fostering trust with their clients and their end-consumers."
More on Rezul News
- New Active Adult Ranch Homes by O'Dwyer Now Selling at Highly Anticipated Lake Society on Lake
- O'Dwyer Homes Introduces Bridgeview, New Semi-Custom Homes near Downtown Canton
- Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
- OKC Roofer Releases "Ultimate End-of-Year Roof Checklist" to Help Homeowners Prepare for Winter
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society
As an independent observer, Remedy Review hopes its Seal of Approval will aid consumers in a confusing space by adding an additional layer of scrutiny to a growing online marketplace.
A summary of test results can be found at https://www.remedyreview.com/industry/lab-test-results.
About Remedy Review
Remedy Review is dedicated to advancing the wellness of people. Since its launch in October of 2018, the site has published articles on the medical, economic, and lifestyle potential of hemp. For people buying CBD online, Remedy Review is the only product review site that uses 3rd-party testing to protect consumers and hold brands accountable.
For more information, please visit: https://www.remedyreview.com
About Avazyme, Inc.
Avazyme, Inc. offers custom-tailored testing solutions for agriculture, pesticide and biopesticide, biotechnology and pharmaceutical industries and the entire food value chain, performed under the highest quality standards, including GLPs. The founder, President and CEO of Avazyme, Volker Bornemann, Ph.D., is also an adjunct professor at NCSU and on the AgTech Scientific Advisory Board of the North Carolina Biotechnology Center. Avazyme has acquired the state and federal permits to legally handle any controlled substances (DEA Schedule 1 through 5), including Cannabis and products derived thereof, at its laboratory facility.
For more information, please visit: https://www.avazyme.com
More on Rezul News
- Beycome Closes $2.5M Seed Round Led by InsurTech Fund
- Tatanka Run Announces Phase-2 Development Following Completion of Phase-1 Spec Home
- Tru by Hilton Columbia South Opens to Guests
- Christy Sports donates $56K in new gear to SOS Outreach to help kids hit the slopes
- PulteGroup Northeast Florida's 4th Annual Building Hope Golf Tournament raises record $224,331
CONTACT:
Marc Lewis
Executive Editor
marc@remedyreview.com
LEGAL:
Remedy Review does NOT provide any medical advice, diagnosis, or treatment. If you need medical advice, diagnosis, or treatment, please see a physician and do NOT use Remedy Review for that purpose. Further, Remedy Review does not and cannot recommend treatment or offer medical advice on personal health matters. The contents contained herein and on remedyreview.com, including but not limited to all product information, are for informational purposes only and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. The contents on remedyreview.com shall not be used as a substitute for professional diagnosis or treatment. Your access to or use of the remedyreview.com does not create in any way a physician-patient relationship, any sort of confidential relationship, or any other relationship that would give rise to any duties on the part of Remedy Review, its agents, or employees. Always seek the advice of a qualified healthcare professional with any questions you may have regarding any medical condition. Never disregard medical advice or delay in seeking medical advice because of something you have read on remedyreview.com. In case of an emergency, call 911 for immediate assistance. Remedy Review makes best efforts to present accurate information in its testing and works with highly credentialed ISO-certified laboratories to produce test results. Neither Remedy Review nor any party involved in creating, producing or delivering remedyreview.com shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user's access, use, or inability to use remedyreview.com, or any errors or omissions in the content of remedyreview.com.
SOURCE Remedy Review
Related Links
https://www.remedyreview.com
Filed Under: Business
0 Comments
Latest on Rezul News
- Golden Paper Identifies Global Growth in Packaging Papers and Upgrades Its High-End Production Capacity
- Champagne, Caviar Bumps & Pole Performances — Welcome the New Year Early with HandPicked Social Club
- A New Soul Album: Heart Of Kwanzaa, 7-Day Celebration
- Allegiant Management Group Named 2025 Market Leader in Orlando by PropertyManagement.com
- NAFMNP Awarded USDA Cooperative Agreement to Continue MarketLink Program Under FFAB
- Costa Oil - 10 Minute Oil Change Surpasses 70 Locations with Construction of San Antonio, TX Stores — Eyes Growth Via Acquisition or Being Acquired
- LaTerra and Respark Under Contract with AIMCO to Acquire a $455M, 7-Property Chicago Multifamily Portfolio
- PulteGroup opens new model, now selling at Murray Farms
- Amazing Hotels Inc Announces A Luxury Hotel & Entertainment Complex On 500+/- Lakefront Acres
- Capital Has Gone Global. Real Estate Hasn't. Why 2026 Marks a Turning Point
- Record Revenue, Tax Tailwinds, and AI-Driven Scale: Why Off The Hook YS Inc. Is Emerging as a Standout in the $57 Billion U.S. Marine Market
- VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
- Children Rising Appoints Marshelle A. Wilburn as New Executive Director
- New Homes for sale in Smithville Texas
- Fairmint CEO Joris Delanoue Elected General Director of the Canton Foundation
- Sleep Basil Mattress Co.'s Debuts New Home Page Showcasing Performance Sleep Solutions for Active Denver Lifestyles
- Bent Danholm Joins The American Dream TV as Central Florida Host
- The Nature of Miracles Celebrates 20th Anniversary Third Edition Published by DreamMakers Enterprises LLC
- Artificial Intelligence Leader Releases Children's Book on Veterans Day
- RealEstateRelated.com Completes Pre-Seed Equity Round to Advance AI Infrastructure